Terns Pharmaceuticals Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) Transcript
Hello, everyone. I am Jay Olson, one of the biotech analysts here at Oppenheimer, and it's really an honor to introduce Terns Pharmaceuticals at our fall healthcare conference. We have been doing a lot of work in the NASH space, so it's a pleasure to host CFO, Mark Vignola, today. I know you guys recently completed enrollment in your AVIATION study. So a lot of exciting things going on at Terns.
If you have any questions that you'd like me to ask Mark, please feel free to submit them or you can email me at [email protected]. And with that, we'll get started.
Thank you, Mark, so much for joining us today.
Thank you so much, Jay, and I just want to thank the entire Oppenheimer team for inviting us to the conference and allowing us to participate today and tell everybody about the Terns story. Just want to remind everybody that before we begin, we will be making certain forward-looking statements and you can find all of the relevant disclosures on the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
